AI Boosts Healthcare Stocks, But Not for Buy Signals

Healthcare stocks may rise from AI integration in medical diagnostics and drug discovery. The increase stems from AI improving clinical trial efficiency and accelerating drug development. Investors should not assume AI-driven gains justify immediate purchases. The underlying financial drivers remain operational and regulatory performance.